Back to the full story3 sources · Moderna’s Shift to Cancer Company Lifts Stock Up 177%◆ Analytics
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
Deterministic text analytics computed across all 3 sources. Frequency, entity overlap, and claim overlap — computed counts only. Nothing is rated true or false.
01
Frequency Analytics
The most common words and exact phrases across every report in this cluster. Computed counts only.
Top words
modernacancerstockbreakthroughcompanyplummetedsomethingfortunescrateredvaccines
Top phrases
moderna stock
02
Entity Overlap
Names detected in the report text: which appear across multiple sources, and which only one source mentions.
Across multiple sources
None mentioned by more than one source.
Unique to one source
- Covid · The New York Times
- After Moderna · Yahoo Finance
- Wall Street · Yahoo Finance
- A Phase · Decrypt
03
Claim Overlap
Near-identical sentences found in two or more reports, versus sentences that appear in only one. Text match only — nothing is rated true or false.
Repeated across sources
No sentence appeared in more than one source.
Appears once
- "The company’s fortunes cratered as demand for Covid-19 vaccines plummeted." · The New York Times
- "A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion." · Decrypt
